State of Wisconsin Investment Board’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
22,483
+1,157
+5% +$652K 0.02% 587
2026
Q1
$12.6M Sell
21,326
-327
-2% -$163K 0.03% 544
2025
Q4
$10.6M Sell
21,653
-735
-3% -$342K 0.02% 651
2025
Q3
$9.39M Sell
22,388
-13,338
-37% -$4.49M 0.02% 676
2025
Q2
$10.3M Buy
35,726
+813
+2% +$243K 0.03% 628
2025
Q1
$10.8M Sell
34,913
-1,708
-5% -$585K 0.03% 595
2024
Q4
$12.9M Buy
36,621
+3,220
+10% +$1.18M 0.03% 511
2024
Q3
$12M Buy
33,401
+7,307
+28% +$2.47M 0.03% 547
2024
Q2
$8.31M Sell
26,094
-4,253
-14% -$1.13M 0.02% 698
2024
Q1
$6.97M Sell
30,347
-4,974
-14% -$1.12M 0.02% 818
2023
Q4
$7.77M Buy
35,321
+10,396
+42% +$2.4M 0.02% 766
2023
Q3
$5.63M Sell
24,925
-7,381
-23% -$1.7M 0.02% 869
2023
Q2
$7.13M Sell
32,306
-2,148
-6% -$476K 0.02% 774
2023
Q1
$7.72M Sell
34,454
-19,650
-36% -$4.84M 0.02% 720
2022
Q4
$15M Sell
54,104
-522
-1% -$132K 0.05% 396
2022
Q3
$11.4M Buy
54,626
+1,084
+2% +$242K 0.04% 496
2022
Q2
$12.6M Buy
53,542
+6,952
+15% +$1.41M 0.03% 537
2022
Q1
$8.36M Buy
46,590
+41,223
+768% +$7.85M 0.02% 885
2021
Q4
$1.16M Sell
5,367
-163
-3% -$32K ﹤0.01% 1406
2021
Q3
$1.02M Buy
5,530
+259
+5% +$51K ﹤0.01% 1443
2021
Q2
$946K Sell
5,271
-233
-4% -$44.4K ﹤0.01% 1471
2021
Q1
$921K Sell
5,504
-82
-1% -$13.7K ﹤0.01% 1391
2020
Q4
$848K Sell
5,586
-230
-4% -$30.2K ﹤0.01% 1370
2020
Q3
$587K Buy
5,816
+110
+2% +$12.1K ﹤0.01% 1422
2020
Q2
$690K Sell
5,706
-150
-3% -$16.9K ﹤0.01% 1329
2020
Q1
$555K Sell
5,856
-1,900
-24% -$181K ﹤0.01% 1322
2019
Q4
$683K Hold
7,756
﹤0.01% 1346
2019
Q3
$619K Sell
7,756
-23
-0.3% -$1.85K ﹤0.01% 1261
2019
Q2
$607K Buy
+7,779
New +$727K ﹤0.01% 1269
2018
Q3
Sell
-28,205
Closed -$3.19M 1558
2018
Q2
$3.19M Sell
28,205
-16,997
-38% -$1.87M 0.01% 933
2018
Q1
$5.08M Sell
45,202
-759
-2% -$96.4K 0.01% 844
2017
Q4
$6.8M Buy
45,961
+802
+2% +$102K 0.02% 780
2017
Q3
$5.29M Buy
45,159
+4,644
+11% +$593K 0.02% 830
2017
Q2
$5.26M Buy
+40,515
New +$5.05M 0.02% 812
2017
Q1
Sell
-4,659
Closed -$668K 1313
2016
Q4
$668K Buy
+4,659
New +$595K ﹤0.01% 1226
2016
Q2
Sell
-57,611
Closed -$6.42M 1343
2016
Q1
$6.42M Buy
+57,611
New +$7.29M 0.03% 669
2015
Q4
Sell
-15,311
Closed -$2.01M 1329
2015
Q3
$2.01M Buy
+15,311
New +$2.46M 0.01% 1112
2015
Q2
Sell
-61,231
Closed -$10.6M 1369
2015
Q1
$10.6M Sell
61,231
-36,990
-38% -$5.64M 0.04% 541
2014
Q4
$12.7M Buy
98,221
+12,650
+15% +$1.63M 0.04% 468
2014
Q3
$11M Sell
85,571
-35,760
-29% -$3.69M 0.04% 509
2014
Q2
$10.7M Sell
121,331
-6,610
-5% -$636K 0.04% 530
2014
Q1
$12M Sell
127,941
-38,460
-23% -$3.93M 0.05% 480
2013
Q4
$18.8M Buy
166,401
+74,010
+80% +$6.67M 0.07% 326
2013
Q3
$7.29M Sell
92,391
-4,770
-5% -$349K 0.03% 656
2013
Q2
$6.39M Buy
+97,161
New +$6.26M 0.03% 702

Other funds holding UTHR

State of Wisconsin Investment Board's UTHR Position: Q2 2026 in Review

State of Wisconsin Investment Board increased its United Therapeutics (UTHR) stake by 5.4% in Q2 2026, buying an estimated $652K and bringing the position to 22,483 shares worth $12.2M. The position accounts for 0.02% of the portfolio, ranked #587.

State of Wisconsin Investment Board first reported a position in UTHR in Q2 2013 and has held it in 45 quarters since. The position peaked at $18.8M in Q4 2013. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • State of Wisconsin Investment Board held 22,483 shares of United Therapeutics worth $12.2M as of Q2 2026.
  • State of Wisconsin Investment Board bought 1,157 United Therapeutics shares in Q2 2026, an estimated $652K.
  • United Therapeutics made up 0.02% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #587 holding.
  • State of Wisconsin Investment Board first reported a position in United Therapeutics in Q2 2013 and has held it in 45 quarters since.
  • State of Wisconsin Investment Board's United Therapeutics position peaked at $18.8M in Q4 2013.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.